Audion Therapeutics and REGAIN Consortium Announce Positive Results from Phase I Study of Notch Inhibitor LY3056480 in Patients with Sensorineural Hearing Loss February 5, 2019https://www.b3cnewswire.com/201902051883/audion-therapeutics-and-regain-consortium-announce-positive-phase-i-results-in-patients-with-sensorineural-hearing-loss.html
